Pasithea Therapeutics Abstract Accepted for Poster Presentation at 2023 Neurofibromatosis Conference
01 juin 2023 07h57 HE
|
Pasithea
PALO ALTO, Calif. and MIAMI, June 01, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research,...
![desc](http://www.globenewswire.com/fr/Attachment/LogoDisplay/288507?filename=288507.jpg&size=2)
Alzheimer's Drug Discovery Foundation and Children's Tumor Foundation announce Partnership to Provide Drug Discovery Resources for Research Community
14 mars 2014 10h31 HE
|
Children's Tumor Foundation
NEW YORK, N.Y., March 14, 2014 (GLOBE NEWSWIRE) -- The Alzheimer's Drug Discovery Foundation (ADDF) and The Children's Tumor Foundation (CTF) today announced a partnership to provide CTF's scientific...
![desc](http://www.globenewswire.com/fr/Attachment/LogoDisplay/287803?filename=287803.jpg&size=2)
Children's Tumor Foundation Announces Historic New Initiative in Neurofibromatosis Research
10 mars 2014 11h33 HE
|
Children's Tumor Foundation
NEW YORK, March 10, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation, the leading non-governmental organization dedicated to neurofibromatosis (NF) research, announced today an important new...
![Annette Bakker](http://www.globenewswire.com/fr/Attachment/LogoDisplay/280781?filename=280781.jpg&size=2)
Children's Tumor Foundation Announces Leadership Change
15 janv. 2014 14h16 HE
|
Children's Tumor Foundation
NEW YORK, Jan. 15, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation (CTF) announced today that Annette Bakker, Chief Scientific Officer of the Foundation has been elevated to President,...